HGH (Somatropin): FDA-approved for specific indications: pediatric growth hormone deficiency, adult GHD, Turner syndrome, HIV/AIDS-related wasting, short bowel syndrome Prescription-only medication requiring physician monitoring Illegal to distribute for off-label purposes including anti-aging (per the 1990 Anabolic Steroids Control Act amendments) Brand names include Genotropin, Norditropin, Humatrope, Saizen CJC-1295 and Ipamorelin: Neither is FDA-approved for any therapeutic indication Available as research compounds for laboratory use only (RUO Research Use Only) Not scheduled substances, but not approved for human therapeutic use Ipamorelin has undergone Phase I/II clinical trials (Johansen et al., 1999) but development did not progress to approval For a deeper look at Ipamorelin's regulatory history, see our Ipamorelin FDA approval status guide
Further evidence of GSH enhancement of the immune cells effector mechanisms against M
Age-related decline in growth hormone, cellular repair capacity, and metabolic function can slow response times
Trends Biochem Sci 38(11):556565
Is Glutathione itself halal
Pharmacokinetics of curcumin delivered by nanoparticles and the relationship with antitumor efficacy: a systematic review
